Kyongbo Pharmaceutical Co Ltd
KRX:214390
Kyongbo Pharmaceutical Co Ltd
KRX:214390
Price:
7 960
KRW
11.33%
Market Closed
Market Cap:
₩190.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
KR |
|
W
|
Warner Bros Discovery Inc
XMUN:J5A
|
US |
|
I
|
Ingram Micro Holding Corp
NYSE:INGM
|
US |
|
Companhia de Fiacao e Tecidos Cedro Cachoeira
BOVESPA:CEDO3
|
BR |
|
Ootoya Holdings Co Ltd
TSE:2705
|
JP |
|
F
|
Fuji Glass Co Ltd
TSE:5212
|
JP |
|
Natural Gas Services Group Inc
NYSE:NGS
|
US |
|
Cyber Com Co Ltd
TSE:3852
|
JP |
Relative Value
The Relative Value of one
Kyongbo Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 7 960 KRW,
Kyongbo Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kyongbo Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Kyongbo Pharmaceutical Co Ltd Competitors
Kyongbo Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
190.3B KRW | 0.7 | 1 043.9 | 18.5 | 88 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
